DIDO-2 explained

DIDO-2 (COSPAR 2017-008BE) is a nano-satellite of the Israeli / Swiss company SpacePharma.^[1] The nano-satellite is part of a research project whose goal is to test a miniaturized end-to-end pharmaceutical laboratory (called ) in space under microgravity conditions. The project includes two satellites called DIDO-1 and DIDO-2. The platforms of the 3U CubeSats are developed and built by the Dutch company ISIS.^[2]

The first satellite DIDO-1 was originally to fly on a Falcon 9 in 2016. The current (as of 2019) status and plans for this satellite are unknown.^[3]

DIDO-2 was successfully launched on February 15, 2017, at 3:58 UTC from Satish Dhawan Space Centre on a PSLV-XL rocket (mission PSLV-C37) that released 104 satellites.^[4]

In 2018, a third mission, DIDO-3 was being planned.^[3]

Specifications

DIDO-2 is a 3U CubeSat, weighing 4.2 kg.^[5]

Notes and References

1. https://directory.eoportal.org/web/eoportal/satellite-missions/c-missions/cartosat-2d CartoSat-2D
2. https://www.isispace.nl/wp-content/uploads/2017/02/Missions.pdf ISIS supported CubeSats
3. Web site: Dido 1, 2.
4. Global . IndraStra . India's ISRO Successfully Launched 104 Satellites in a Single Mission . IndraStra . 2381-3652.
5. Web site: India lofts a record 104 spacecraft on a single rocket . Stephen . Clark . February 15, 2017 . Spaceflight Now.